Frankfurt - Delayed Quote EUR
NuCana plc (N04.F)
0.0300
+0.0200
+(200.00%)
At close: May 15 at 9:30:22 AM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
14,774
27,811
58,254
77,474
Total Liabilities Net Minority Interest
8,820
12,924
19,752
11,926
Total Equity Gross Minority Interest
5,954
14,887
38,502
65,548
Total Capitalization
5,954
14,887
38,502
65,548
Common Stock Equity
5,954
14,887
38,502
65,548
Capital Lease Obligations
190
396
639
371
Net Tangible Assets
3,755
12,759
36,137
63,138
Working Capital
3,599
12,343
35,610
59,897
Invested Capital
5,954
14,887
38,502
65,548
Tangible Book Value
3,755
12,759
36,137
63,138
Total Debt
190
396
639
371
Share Issued
98,130
52,860.3350
52,372.8870
52,179.9790
Ordinary Shares Number
98,130
52,360.3350
51,872.8870
52,179.9790
Treasury Shares Number
--
500
500
--
12/31/2021 - 4/5/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6C1.F CytomX Therapeutics, Inc.
2.0700
+0.88%
6C1.BE CytomX Therapeutics Inc
1.7840
-14.97%
226950.KQ OliX Pharmaceuticals, Inc
43,600.00
-5.93%
6C1.SG CytomX Therapeutics Inc
2.0420
-1.54%
6C1.DU CytomX Therapeutics Inc
1.7980
-9.24%
HEMO.L Hemogenyx Pharmaceuticals Plc
178.00
-0.42%
POLB.L Poolbeg Pharma PLC
2.8500
-1.72%
NRX.V NurExone Biologic Inc.
0.6800
-1.45%
NXTC NextCure, Inc.
0.4120
-7.33%
REVB Revelation Biosciences, Inc.
3.0300
-3.50%